Medicare Enrolled

Dr. Gopal Gadodia, M.D.

Cardiovascular Disease · Melbourne, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2200 W EAU GALLIE BLVD, Melbourne, FL 32935
3212551500
In practice since 2005 (20 years)
NPI: 1306842984 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gadodia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gadodia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gadodia

Dr. Gopal Gadodia is a cardiovascular disease in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Gadodia performed 9,203 Medicare services across 3,744 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gadodia received a total of $2,900 from 19 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gadodia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 8% volume in FL$ $2,900 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,203
Medicare services
Top 8% in FL for cardiovascular disease
3,744
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~460 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)3,971$0$2
Office visit, established patient (30-39 min)690$89$270
Electrocardiogram (EKG), 12-lead677$10$43
Injection, dipyridamole, per 10 mg611$3$5
Office visit, established patient (20-29 min)542$63$183
Hospital follow-up visit, high complexity490$94$265
Technetium tc-99m sestamibi, diagnostic, per study dose348$85$150
Echocardiogram, transthoracic330$144$561
Hospital follow-up visit, moderate complexity304$63$184
Initial hospital admission, moderate complexity188$104$350
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician182$48$190
Nuclear medicine studies of heart muscle at rest and with stress and spect174$330$1,193
New patient office visit (45-59 min)103$123$415
Programming of dual lead pacemaker system93$26$146
Ultrasound of heart, follow-up71$20$76
Remote pacemaker monitoring, 90 days52$23$87
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes49$38$127
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes44$68$261
Cardiac catheterization35$791$2,513
New patient office visit (30-44 min)31$84$273
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes25$9$27
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional24$20$67
Hospital discharge day management, 30 minutes or less24$65$184
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional22$627$1,745
Programming of dual lead implantable defibrillator system19$42$205
Coronary stent placement17$458$1,800
Initial hospital admission, high complexity17$139$517
Evaluation of single, dual, multiple lead or leadless pacemaker system14$16$94
Ultrasound of heart with probe in esophagus, with report14$84$252
Ultrasound of heart blood flow, valves and chambers14$14$134
Ultrasound of heart with color-depicted blood flow, rate and valve function14$2$63
Injection for imaging of aorta above heart valve with review by radiologist14$32$344
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
54.6% medium
38.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,900
Total received (2018-2024)
Avg $414/year across 7 years
Bottom 47% in FL for cardiovascular disease
19
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,886 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$99
2023
$421
2022
$1,308
2021
$363
2020
$159
2019
$121
2018
$431

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Cardiovascular Systems Inc.
$1,253
Abbott Laboratories
$272
Medtronic, Inc.
$251
CVRx, Inc.
$209
ShockWave Medical, Inc
$118
Novartis Pharmaceuticals Corporation
$115
LivaNova USA, Inc.
$100
Lundbeck LLC
$91
Janssen Pharmaceuticals, Inc
$91
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$90
AstraZeneca Pharmaceuticals LP
$80
ABIOMED
$69
PFIZER INC.
$47
Siemens Medical Solutions USA, Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Merck Sharp & Dohme Corporation
$19
Medtronic Vascular, Inc.
$17
AngioDynamics, Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 61.2% of total payments
Associated products mentioned in payments ›
Artis Q floor · Auryon Laser System 100-120 Vac · BRILINTA · Barostim Neo System · COREVALVE EVOLUT R · Diamondback Peripheral · ELIQUIS · ENTRESTO · Edarbyclor · FARXIGA · Impella · JARDIANCE · LIFESPARC · LifeVest · MINI TREK · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NORTHERA · Peripheral Orbital Atherectomy System · Resolute · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · VERQUVO · VYNDAQEL · XARELTO · XIENCE SIERRA · Xience Sierra CSS
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $32 per 100 Medicare services performed
Looking for a cardiovascular disease in Melbourne?
Compare cardiovascular diseases in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
38
Per 100K population
6.1
County median income
$75,817
Nearest hospital
ORLANDO HEALTH MELBOURNE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gadodia is a clinical cardiology specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gadodia experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Gadodia performed 3,971 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gadodia receive payments from pharmaceutical companies?
Yes. Dr. Gadodia received a total of $2,900 from 19 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gadodia's costs compare to other cardiovascular diseases in Melbourne?
Dr. Gadodia's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gadodia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →